Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Shrinking team NBB
FTE fell two years in a row, from 6.4 to 4.4.
Financials
Financial year 2025
PHARMACIE DU BON AIR from Anderlecht, company number BE0458555028, closed financial year 2025 with a result of € 45,437 after tax. For that financial year PHARMACIE DU BON AIR recorded a gross margin of € 461,013 and equity of € 626,250. Compared with financial year 2024, the result moved from € 147,562 to € 45,437. The company is profitable. The company holds a healthy buffer. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on July 24, 2026.
€ 626,250
▼ 30% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 45,437
▼ 69% vs 2024
Profit after tax over the fiscal year.
€ 348,039
▼ 22% vs 2024
Cash and bank balances on the last day of the fiscal year.
€ 319,287 paid out
More than the year’s profit went to the shareholders; reserves fell.
People and assets in 2025
4.4
▼ 0.4 vs 2024
Average over the fiscal year, from the social balance sheet.
€ 289,430
▲ 25% vs 2024
€ 65,800 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 99,419
▲ € 85,075 vs 2024
Of which on lease € 78,866.
Debts at end 2025
€ 551,638
▼ 2% vs 2024
€ 84,337 is repaid this year. At this pace the long-term loan is gone in ≈ 7 years.
€ 283,982
▲ 16% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 47,436
▼ 17% vs 2024
Taxes, VAT and social contributions still to pay.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 651,394 | € 551,099 | € 532,065 | € 461,013 | ▼ 13% |
| Profit after taxes | € 166,083 | € 143,934 | € 147,562 | € 45,437 | ▼ 69% |
| Equity | € 742,172 | € 853,100 | € 900,100 | € 626,250 | ▼ 30% |
| Total debts | € 1,187,480 | € 1,069,392 | € 972,346 | € 1,210,602 | ▲ 25% |
| Cash | € 599,004 | € 419,497 | € 445,252 | € 348,039 | ▼ 22% |
| Land & buildings | € 212,104 | € 205,708 | € 199,312 | € 192,916 | ▼ 3% |
| Retained profit | € 704,972 | € 815,900 | € 862,900 | € 589,050 | ▼ 32% |
| Dividend | € 75,000 | € 33,007 | € 100,562 | € 319,287 | ▲ 218% |
| Bank debt | € 706,559 | € 635,254 | € 565,046 | € 551,638 | ▼ 2% |
| Balance sheet total | € 1,929,652 | € 1,922,492 | € 1,872,446 | € 1,836,852 | ▼ 2% |
| Employees (FTE) | 6.8 | 6.4 | 4.8 | 4.4 | ▼ 0.4 |
Key figures of PHARMACIE DU BON AIR, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to PHARMACIE DU BON AIR?
What happened at PHARMACIE DU BON AIR in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 45,437 (▼ 69% vs 2024). Source: NBB ↗
- New establishment in Anderlecht. KBO
- Start of the company according to the CBE. KBO
In short
From € 166,083 profit in 2022 to € 45,437 profit in 2025.
Paid € 226,366 in corporate taxes since 2022.
Best year ever: 2022, with € 166,083 profit.
On average € 104,800 of value added per employee in 2025.
A new publication or filing at PHARMACIE DU BON AIR? We notify you, reason included.
Follow PHARMACIE DU BON AIRDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Behind PHARMACIE DU BON AIR are Bénédicte GIROUL and Daniel DE RON. The same people are also behind PAPAVER SCIENTIFIC COMMUNICATION.
Directors
According to the 2025 annual accounts
Establishments
Establishment units
Physical locations of this company
Itterbeekse Laan 394
1070 Anderlecht
Itterbeekse Laan 402
1070 Anderlecht
Active since 11 September 1996
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0458.555.028
- VAT number
- BE 0458.555.028
- Registered office
- Itterbeekse Laan 394, 1070 Anderlecht
- Names & denominations
- PHARMACIE DU BON AIR
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 24 July 1996
- Peppol
- Active · Active since 13 Jan 2026
- Activities · NACE
Detailhandel in farmaceutische producten
Apothekers